Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1984 Jun;92(3):285–296. doi: 10.1017/s0022172400064524

The duration of immunity in cattle following inoculation of rinderpest cell culture vaccine.

W Plowright
PMCID: PMC2129311  PMID: 6736639

Abstract

The duration of immunity following a single administration of rinderpest cell culture vaccine, of 90 or more monolayer passages, was studied in E. African zebu (Boran) and grade (cross-bred European) cattle. All animals were kept for periods of 6-11 years in rinderpest-free environments; groups of them (in all 23 Borans and 10 grades) were then challenged by parenteral or intranasal inoculation of virulent virus or by contact exposure to reacting cattle. Nasal excretion of virus was studied daily over the 10-to 14-day period following challenge, and simultaneous attempts were made to detect viraemia. The neutralizing antibody response was followed at 6-month intervals over the whole post-vaccination period and then daily for 10 days and at longer intervals to 3 weeks after challenge. All 33 animals which were exposed by various routes failed to react clinically and a rinderpest viraemia was never detected. No transmission of virus from the vaccinates to susceptible in-contact controls occurred within 14 or more days, from the 20 animals which could be so tested. Clearcut serological responses to challenge were seen in six cattle (four Borans and two grades) which were challenged after 7 years or more; these reactions were all delayed to the 9th or 10th days, i.e. they were not typically 'anamnestic'. These results are discussed in relation to mass vaccination campaigns for the control of rinderpest and from the comparative viewpoint of measles vaccination in man.

Full text

PDF
285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J., Rowe L. W., Taylor W. P., Crowther J. R. An enzyme-linked immunosorbent assay for the detection of IgG, IgA and IgM antibodies to rinderpest virus in experimentally infected cattle. Res Vet Sci. 1982 Mar;32(2):242–247. [PubMed] [Google Scholar]
  2. Brown P., Gajdusek D. C., Tsai T. Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine. Am J Epidemiol. 1969 Dec;90(6):514–518. doi: 10.1093/oxfordjournals.aje.a121097. [DOI] [PubMed] [Google Scholar]
  3. DEBOER C. J., BARBER T. L. SEGREGATION OF AN AVIRULENT VARIANT OF RINDERPEST VIRUS BY THE TERMINAL DILUTION TECHNIQUE IN TISSUE CULTURE. J Immunol. 1964 Jun;92:902–907. [PubMed] [Google Scholar]
  4. Kalis J. M., Quie P. G., Balfour H. H., Jr Measles (rubeola) susceptibility among elementary schoolchildren. Am J Epidemiol. 1975 Jun;101(6):527–531. doi: 10.1093/oxfordjournals.aje.a112124. [DOI] [PubMed] [Google Scholar]
  5. Krugman S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr. 1971 Jan;78(1):1–16. doi: 10.1016/s0022-3476(71)80259-7. [DOI] [PubMed] [Google Scholar]
  6. Krugman S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr. 1977 Jan;90(1):1–12. doi: 10.1016/s0022-3476(77)80755-5. [DOI] [PubMed] [Google Scholar]
  7. Linnemann C. C., Jr, Rotte T. C., Schiff G. M., Youtsey J. L. A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol. 1972 Mar;95(3):238–246. doi: 10.1093/oxfordjournals.aje.a121391. [DOI] [PubMed] [Google Scholar]
  8. Nawathe D. R., Lamorde A. G., Kumar S. Recrudescence of rinderpest in Nigeria. Vet Rec. 1983 Aug 13;113(7):156–157. doi: 10.1136/vr.113.7.156. [DOI] [PubMed] [Google Scholar]
  9. Nawathe D. R., Lamorde A. G. Recurrence of rinderpest in Nigeria. Vet Rec. 1982 Sep 4;111(10):203–203. doi: 10.1136/vr.111.10.203-a. [DOI] [PubMed] [Google Scholar]
  10. PLOWRIGHT W., FERRIS R. D. Studies with rinderpest virus in tissue culture. III. The stability of cultured virus and its use in virus neutralization tests. Arch Gesamte Virusforsch. 1962;11:516–533. doi: 10.1007/BF01241304. [DOI] [PubMed] [Google Scholar]
  11. PLOWRIGHT W. STUDIES ON THE PATHOGENESIS OF RINDERPEST IN EXPERIMENTAL CATTLE. II. PROLIFERATION OF THE VIRUS IN DIFFERENT TISSUES FOLLOWING INTRANASAL INFECTION. J Hyg (Lond) 1964 Jun;62:257–281. doi: 10.1017/s0022172400039978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Plowright W., Herniman K. A., Rampton C. S. Studies on rinderpest culture vaccine. I. Some factors affecting virus production. Res Vet Sci. 1969 Jul;10(4):373–381. [PubMed] [Google Scholar]
  13. Plowright W., Taylor W. P. Long-term studies of the immunity in East African Cattle following inoculation with rinderpest culture vaccine. Res Vet Sci. 1967 Jan;8(1):118–128. [PubMed] [Google Scholar]
  14. Provost A., Maurice Y., Borredon C. Comportement clinique et immunologique, lors de contamination bovipestique, de bovins vaccinés depuis plusieurs années contre la peste bovine avec des vaccines de cultures cellulaires. Rev Elev Med Vet Pays Trop. 1969;22(4):453–464. [PubMed] [Google Scholar]
  15. Provost A. Observations sur les muco-anticorps nasaux des bovins. Rev Elev Med Vet Pays Trop. 1970;23(3):283–293. [PubMed] [Google Scholar]
  16. Rossiter P. B., Jessett D. M., Wafula J. S., Karstad L., Chema S., Taylor W. P., Rowe L., Nyange J. C., Otaru M., Mumbala M. Re-emergence of rinderpest as a threat in East Africa since 1979. Vet Rec. 1983 Nov 12;113(20):459–461. doi: 10.1136/vr.113.20.459. [DOI] [PubMed] [Google Scholar]
  17. Rweyemamu M. M., Reid H. W., Okuna N. Observations on the behaviour of rinderpest virus in immune animals challenged intransally. Bull Epizoot Dis Afr. 1974 Mar;22(1):1–9. [PubMed] [Google Scholar]
  18. TAYLOR W. P., PLOWRIGHT W. STUDIES ON THE PATHOGENESIS OF RINDERPEST IN EXPERIMENTAL CATTLE. 3. PROLIFERATION OF AN ATTENUATED STRAIN IN VARIOUS TISSUES FOLLOWING SUBCUTANEOUS INOCULATION. J Hyg (Lond) 1965 Jun;63:263–275. doi: 10.1017/s0022172400045149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Weibel R. E., Buynak E. B., McLean A. A., Roehm R. R., Hilleman M. R. Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines. Proc Soc Exp Biol Med. 1980 Nov;165(2):260–263. doi: 10.3181/00379727-165-40967. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES